MYOCARDIAL INFARCTION IN YOUNG MEN, FEATURES OF CLINICAL COURSE AND STATE OF ERECTILE FUNCTION
No 2 (2021), Clinical medicine
No 2 (2021)

MYOCARDIAL INFARCTION IN YOUNG MEN, FEATURES OF CLINICAL COURSE AND STATE OF ERECTILE FUNCTION

Clinical medicine
https://doi.org/10.31612/2616-4868.2(16).2021.02
Published June 25, 2021
Yu.M. Makukha
State Scientific Institution “Scientific and Practical Center for Preventive and Clinical Medicine” of the State Administration of Affairs
https://orcid.org/0000-0003-4219-3245
A.M. Kravchenko
State Scientific Institution “Scientific and Practical Center for Preventive and Clinical Medicine” of the State Administration of Affairs
https://orcid.org/0000-0001-6863-0197
Ie.V. Andrieiev
Bogomolets National Medical University
https://orcid.org/0000-0002-0727-8166
O.O. Aleksieienko
Alexander Clinical Hospital in Kyiv
https://orcid.org/0000-0002-9096-6460
ARTICLE PDF (Українська)

Keywords

myocardial infarction, erectile dysfunction

How to Cite

Makukha, Y., Kravchenko, A., Andrieiev, I., & Aleksieienko, O. (2021). MYOCARDIAL INFARCTION IN YOUNG MEN, FEATURES OF CLINICAL COURSE AND STATE OF ERECTILE FUNCTION. Clinical and Preventive Medicine, (2), 17-24. https://doi.org/10.31612/2616-4868.2(16).2021.02
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

Aim of the study is to determine the features of the clinical course and study the state of erectile function in young men who have suffered MI.

112 male patients of Caucasian race of the Ukrainian population under the age of 50 (mean 43.21±2.8 years) who have had MI were examined.

Clinical and anamnestic data indicate the similarity of young men who have suffered MI with their peers. Yes, there are no significant differences in the percentage of smokers, burdened family history. Analysis of erectile dysfunction, according to the IIEF-5 questionnaire, indicates the presence of problems in young men who have suffered MI.

All examined patients were admitted to the hospital within 12 hours from the first symptoms of MI, which allowed to perform urgent coronary angiography with subsequent endovascular intervention - stenting. According to the cardiac ventriculography, about half of the patients (50 - 44.6%) had a three-vessel disease despite the young age.

One third of patients received as a beta-blocker the new class of drug of the 3rd generation - nebivalol (37 patients - 33.0%), which is important for young patients, as this drug has no adverse effects on erectile function in men. 44 (39.3%) received bisoprolol, a more common long-term beta-blocker. 31 patients had contraindications to beta-blockers.

 

Conclusions.

  1. Myocardial infarction in young men was characterized by a high frequency of anginal form of the clinical course, multivessel disease of the coronary arteries, lipid profile disorders, a high proportion of patients with erectile dysfunction.
  2. Erectile dysfunction in young men is an early marker of coronary heart disease. All men with ED should undergo a thorough cardiac examination to determine lipid profile and testosterone levels.
  3. In patients with coronary heart disease, the symptoms of ED should be actively identified, initiate targeted lifestyle changes to reduce risks, as well as taken into account when choosing drugs for medical treatment.
https://doi.org/10.31612/2616-4868.2(16).2021.02
ARTICLE PDF (Українська)

References

Demohrafichna sytuatsiia u sichni-veresni 2020 roku: ekspres-vypusk [Demographic situation in January-September 2020: express issue]. Retrieved from http://www.ukrstat.gov.ua/express/expr2020/11/139.pdf.

Kilkist pomerlykh za okremymy prychynamy smerti: arkhiv za 2020 rik [Number of deaths by individual causes of death: archive for 2020]. Retrieved from http://www.ukrstat.gov.ua/operativ/operativ2020/ds/kpops/kpops_u/arh_kpops2020_u.html.

Макуха Ю. М., Андреев Е. В., Кравченко А. Н. (2019). Содержание общего тестостерона и особенности его фракционного состава у проживающих в крупном городском центре мужчин, перенесших інфаркт міокарда в возрасте до 50 лет. Лабораторная диагностика. Восточная Европа, 8, 2, 212-217.

Народжуваність і смертність (на 1000 осіб наявного населення). Retrieved from: http://database.ukrcensus.gov.ua/MULT/Dialog/view.asp?ma=000_0301&ti=%CD%E0%F0%EE%E4%E6%F3%E2%E0%ED%B3%F1%F2%FC+%B3+%F1%EC%E5%F0%F2%ED%B3%F1%F2%FC+%28%ED%E0+1000+%EE%F1%B3%E1+%ED%E0%FF%E2%ED%EE%E3%EE+%ED%E0%F1%E5%EB%E5%ED%ED%FF%29&path=../Quicktables/POPULATION/03/01/&lang=1&multilang=uk

Проблема ожирения: краткие статистические данные. Retrieved from: https://www.euro.who.int/ru/health-topics/noncommunicable-diseases/obesity/data-and-statistics

Еректильна дисфункція як предиктор ризику розвитку серцево-судинних захворювань у чоловіків із цукровимдіабетом 2-го типу (2019) / Тронько М.Д., Лучицький Є.В., Лучицький В.Є., Соколова Л.К. та ін. Endokrynologia, 24, 2. DOI: 10.31793/1680-1466.2019.24-2.171

2012 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC) (2012) / Steg G. et al. European Heart Journal, 33, 20, 2569–2619.

2018 ESC/EACTS Guidelines on myocardial revascularization (2019) / Neumann F. J. et al. Europeanheartjournal, 40, 2, 87–165.

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2020). / Mach F. et al. European heart journal,. 41, 1, 111–188.

Erectile dysfunction as a predictor of 2-year prognosis in acute myocardial infarction (2017). / Apostolovic D., Stanojevic R., Jankovic-Tomasevic et al.. Clinical cardiology, 24, 4. DOI: 10.5603/CJ.a2017.0006

Nebivolol exerts beneficial effects on endothelial function, early endothelial progenitor cells, myocardial neovascularization, and left ventricular dysfunction early after myocardial infarction beyond conventional β1-blockade (2011). / Sorrentino S.A., Doerries C., Manes C., Speer T., Dessy C., Lobysheva I., et al.. J AmCollCardiol., 1, 57(5), 601-11. doi: 10.1016/j.jacc.2010.09.037

Sharp R., Gales B. (2017). Nebivolol versus other beta blockers in patients with hypertension and erectile dysfunction. TherAdv Urol., 9(2), 59–63. doi:10.1177/ 1756287216685027

Prediction of Cardiovascular Events and All-Cause Mortality With Erectile Dysfunction: A systematic review and meta-analysis of cohort studies (2013). / Vlachopoulos C.V., Terentes-Printzios D.G., Ioakeimidis N.K. et al. Circcardiovascqual outcomes, Jan 8.

Vroege J. A. (1999). The sexual health inventory for men (IIEF-5). International journal of impotence research, 11, No 3, 177.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.